Rare intracranial recordings show how low-frequency brain signals disappear during symptom relief associated with tirzepatide and resurface weeks before the eating disorder relapses. study: Brain activity...
Posted by: Joey Garcia November 17, 2025 | 10 minutes read | share summary The Department of Endocrinology, Diabetes and Metabolism at the University of Miami...
A rare glimpse into the brain activity of obese and out-of-control patients who took Tirzepatide, sold as Munjaro and Zepbound, reveals that the drug suppresses signaling...
Scientists have revealed how a mother's exposure to type 1 diabetes during pregnancy epigenetically “reprograms” her child's immune system, providing new clues for lifelong protection against...
WASHINGTON (AP) — President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and lower prices for popular...
People with type 2 diabetes who combined a healthy lifestyle with a GLP-1 receptor agonist (GLP-1 RA) drug had a significantly reduced risk of serious cardiovascular...
Recent Comments